Clinical Trial Update: Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial comparing autologous serum, umbilical cord blood–derived drops, and platelet lysate for treating dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Autologous Serum
• Platelet Lysate (platelet lysate)
• umbilical cord blood–derived drops

Snippet

Sponsor: G.Gennimatas General Hospital | Conditions: Dry Eye Disease (DED) | Phase 1, Phase 2 | Status: COMPLETED